Table 1.
ALT(U/L) | AST(U/L) | Albumin (g/dL) | |
---|---|---|---|
Normal control group | 38.25 ± 3.576 | 40.125 ± 3.399 | 3.225 ± 0.409 |
Infected control group (group I) | 140 ± 52.372 | 214.875 ± 52.305 | 2.175 ± 0.227 |
P | ˂0.001*** | ˂0.001 *** | ˂0. 01** |
PZQ treated group (group II) | 78.875 ± 20.911 | 108.75 ± 30.269 | 3.262 ± 0.507 |
P | ˂ 0.05* | ˂0. 01** | ˃0.05 ns |
P1 | ˂0. 01** | ˂0.001*** | ˂0. 01** |
P2 | ˃0.05 ns | ˃0.05 ns | ˃0.05 ns |
MSCs treated group (group III) | 62.75 ± 15.908 | 76.625 ± 26.715 | 3.213 ± 0.611 |
P | ˃0.05 ns | ˃0.05 ns | ˃0.05 ns |
P1 | ˂0.001*** | ˂0.001*** | ˂0.01** |
P indicates significance vs. non-infected control group.
P1 indicates significance vs. infected control group.
P2 indicates significance of PZQ treated group vs. MSCs treated group.
ns: non-significant, * P values ˂ 0.05, ** P values ˂ 0.01, and *** P values ˂ 0.001